Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Lymphoid 1

Conditions

Rare Diseases 1Neoplasm, Residual 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Genetic Predisposition to Disease 1

Interventions

Exercise 419Blood Specimen Collection 319Standard of Care 299Surveys and Questionnaires 242Radiosurgery 239Magnetic Resonance Spectroscopy 232Educational Status 223Methods 221Radiotherapy 216Early Intervention, Educational 200Interviews as Topic 142Practice Guidelines as Topic 141Biopsy 125Surgical Procedures, Operative 119Drug Therapy 119Acupuncture Therapy 119Control Groups 115Therapeutics 101Palliative Care 97Resistance Training 94Counseling 88Saline Solution 87Magnetic Resonance Imaging 84Cyclophosphamide 83Specimen Handling 73Cisplatin 73Radiofrequency Ablation 71Cognitive Behavioral Therapy 71Radiotherapy, Intensity-Modulated 68Colonoscopy 65

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × OTHER × High-Throughput Nucleotide Sequencing × Clear all
NCT06060184 2023-09-29

IonGER

University Hospital Tuebingen

Phase NA Not yet recruiting
500 enrolled

Genetic Predisposition to Disease, Rare Diseases

NCT02339805 2017-07-07

LymphoSeq

Centre Henri Becquerel

Phase NA Completed
30 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Neoplasm, Residual

NCT02420405 2017-02-16

Mutation Detection of EBUS-TBNA Specimens Using NGS

Shanghai Chest Hospital

Phase NA Completed
78 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡